Zhong Yuan Bio-Technology Holdings Ltd
company.status.inactiveCIK 1672886fmd_1GS34YNPK7CW8NZY0W6F5X7VR0Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard
Coverage: Jan 01, 2017 to Mar 31, 2024, 8 periods
Latest annual · FY2024
Millions- Total revenues
- 2
- Gross profit
- 2
- Operating income
- 0
- Net income
- 0
- Free cash flow
- (1)
Latest quarter · Q1 FY2019
Millions- Total revenues
- 0
- Gross profit
- 0
- Operating income
- (0)
- Net income
- (0)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2021 to FY2024
- +11.7%
- Revenue, 5 yearsFY2019 to FY2024
- +13.3%
- Net income, 5 yearsFY2019 to FY2024
- -0.6%
Zhong Yuan Bio-Technology Holdings Ltd financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2024 | FY2023 | Change | Source |
|---|---|---|---|---|
| Revenue | $2.3 million | $1.7 million | +37% | 20-F 2024-11-07 · proof |
| Gross profit | $2.1 million | $1.5 million | +36.5% | 20-F 2024-11-07 · proof |
| Operating income | $266,557 | -$1.6 million | 20-F 2024-11-07 · proof | |
| Net income | $271,869 | -$2.2 million | 20-F 2024-11-07 · proof | |
| Cash from operating activities | -$745,816 | -$1 million | 20-F 2024-11-07 · proof | |
| Total assets | $3.2 million | $2.1 million | +48.5% | 20-F 2024-11-07 · proof |
| Total liabilities | $3.4 million | $2.8 million | +20.3% | 20-F 2024-11-07 · proof |
| Cash and cash equivalents | $145,257 | $277,836 | -47.7% | 20-F 2024-11-07 · proof |
| Total debt | $3.4 million | 20-F 2024-11-07 · proof |
- What was Zhong Yuan Bio-Technology Holdings Ltd's revenue in fiscal 2024?
- Zhong Yuan Bio-Technology Holdings Ltd reported revenue of $2.3 million for fiscal 2024 (the year ended Mar 31, 2024), against $1.7 million the year before (+37%). Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What was Zhong Yuan Bio-Technology Holdings Ltd's gross profit in fiscal 2024?
- Zhong Yuan Bio-Technology Holdings Ltd reported gross profit of $2.1 million for fiscal 2024 (the year ended Mar 31, 2024), against $1.5 million the year before (+36.5%). Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What was Zhong Yuan Bio-Technology Holdings Ltd's operating income in fiscal 2024?
- Zhong Yuan Bio-Technology Holdings Ltd reported operating income of $266,557 for fiscal 2024 (the year ended Mar 31, 2024), against -$1.6 million the year before. Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What was Zhong Yuan Bio-Technology Holdings Ltd's net income in fiscal 2024?
- Zhong Yuan Bio-Technology Holdings Ltd reported net income of $271,869 for fiscal 2024 (the year ended Mar 31, 2024), against -$2.2 million the year before. Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What was Zhong Yuan Bio-Technology Holdings Ltd's cash from operating activities in fiscal 2024?
- Zhong Yuan Bio-Technology Holdings Ltd reported cash from operating activities of -$745,816 for fiscal 2024 (the year ended Mar 31, 2024), against -$1 million the year before. Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What are Zhong Yuan Bio-Technology Holdings Ltd's total assets?
- As of Mar 31, 2024, Zhong Yuan Bio-Technology Holdings Ltd reported total assets of $3.2 million, against $2.1 million a year earlier (+48.5%). Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What are Zhong Yuan Bio-Technology Holdings Ltd's total liabilities?
- As of Mar 31, 2024, Zhong Yuan Bio-Technology Holdings Ltd reported total liabilities of $3.4 million, against $2.8 million a year earlier (+20.3%). Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What are Zhong Yuan Bio-Technology Holdings Ltd's cash and cash equivalents?
- As of Mar 31, 2024, Zhong Yuan Bio-Technology Holdings Ltd reported cash and cash equivalents of $145,257, against $277,836 a year earlier (-47.7%). Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
- What is Zhong Yuan Bio-Technology Holdings Ltd's total debt?
- As of Mar 31, 2024, Zhong Yuan Bio-Technology Holdings Ltd reported total debt of $3.4 million. Source: the 20-F filed with the SEC on Nov 7, 2024. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1672886&period_type=annual&limit=5"Information only, not investment advice.